United States · Investor

Care Capital

Last cheque observed Jan 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries ASeries CDeveloper PlatformField-Programmable Gate Array (FPGA)Venture Capital & Private Equity

Cheques on record
0%of best year0cheques in 12 months, 26 on record
Since the last cheque4304days00hrs00min00sec
Median round$25MRounds led0 of 26Sole investor1 roundsExits4 from the portfolioMostly inUnited States, 96%
Pitch Care Capital

Care Capital highlights

  1. 01

    26 rounds on record

  2. 02

    Mostly Series B and Series A: 56% of its rounds

  3. 03

    Sole investor in 1 rounds, median $9.0M

  4. 04

    4 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
Developer PlatformField-Programmable Gate Array (FPGA)Venture Capital & Private Equity
Based in
Princeton, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first26 appearances

  1. 2015

    1 round

  2. Jan
    CoLucid PharmaceuticalsSeries C · US$37MWith 7 others
  3. 2013

    1 round

  4. Sept
    Inotek PharmaceuticalsDebt · US · inotekcorp.com$7.0MWith 5 others
  5. 2012

    2 rounds

  6. Jul
    Agile TherapeuticsSeries C · US · finsmes.com$40MWith 5 others
  7. Jan
    Elevation PharmaceuticalsSeries B · US · elevationpharma.com$30MWith 4 others
  8. 2011

    3 rounds

  9. Sept
    Elevation PharmaceuticalsSeries A · US · xconomy.com$17MWith 3 others
  10. Aug
    CoLucid PharmaceuticalsSeries B · US · prnewswire.com$7.5MWith 4 others
  11. Jul
    Inotek PharmaceuticalsSeries D · US · sec.gov$24MWith 4 others
  12. 2010

    4 rounds

  13. May
    NormOxysSeries B · US · fiercebiotech.com$18MWith 1 other
  14. Mar
    VaxartSeries B · US · thefreelibrary.com$9.0MSole investor
  15. Jan
    Elevation PharmaceuticalsSeries A · US · finsmes.com$30MWith 3 others
  16. Jan
    MicroCHIPSVenture · US · finsmes.com$17MWith 8 others
  17. 2009

    1 round

  18. Jan
    Anacor PharmaceuticalSeries E · US · bio-medicine.org$50MWith 5 others
  19. 2008

    1 round

  20. Jul
    CoLucid PharmaceuticalsSeries B · US$25MWith 4 others
  21. 2007

    3 rounds

  22. Aug
    Inotek PharmaceuticalsSeries C · US$19MWith 4 others
  23. Jul
    NephroGenexSeries A · US · localtechwire.com$3.3MWith 2 others
  24. Mar
    Orqis MedicalSeries D · US$12MWith 9 others
  25. 2006

    1 round

  26. Mar
    MPVVenture · US · mpv.com$14MWith 4 others
  27. 2005

    1 round

  28. May
    Anacor PharmaceuticalSeries C · US · anacor.com$25MWith 4 others
  29. 2004

    3 rounds

  30. Apr
    Inotek PharmaceuticalsSeries A · US$20MWith 2 others
  31. Apr
    CardiokineSeries A · US$37MWith 3 others
  32. Apr
    ArchemixSeries B · US$50MWith 8 others
  33. 2003

    2 rounds

  34. Jul
    TercicaSeries B · US$44MWith 4 others
  35. Jun
    Orqis MedicalSeries C · US$25MWith 5 others
  36. 2002

    2 rounds

  37. Dec
    RenovoSeries B · GB$33MWith 3 others
  38. Aug
    ArchemixSeries A · US$52MWith 6 others
  39. 2001

    1 round

  40. Jun
    NitroMedSeries E · US$31MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

Elevation PharmaceuticalsBought by Sunovion Pharmaceuticals$430MAug 2012
CardiokineBought by Cornerstone TherapeuticsUndisclosedJan 2012
Anacor PharmaceuticalListedUndisclosedDec 2010
TercicaBought by Ipsen$480MJun 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Care Capital. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Care Capital

What does Care Capital invest in?

Care Capital invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Developer Platform, Field-Programmable Gate Array (FPGA) and Venture Capital & Private Equity.

How active is Care Capital?

26 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2015.

How big are Care Capital's cheques?

The median round it joins is $25M.

Does Care Capital lead rounds?

Rarely, if at all: none of its 26 investments on record names it as the lead.

Where does Care Capital invest?

Most of the companies it backs are in the United States (96%).

Is Care Capital investing now?

No investments in the last 12 months; the latest was in Jan 2015.

Who does Care Capital invest alongside?

Most often Rho Capital Partners (11 rounds together), Domain Associates (5 rounds together) and MedImmune Ventures (5 rounds together).

What kind of investor is Care Capital?

Care Capital is a growth equity firm based in Princeton, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it